X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Qualigen offers a number of revenue-generating therapeutic and diagnostic products that may help Ritter Pharmaceuticals to advance its pipeline and grow its business.
Lead Product(s): AS1411
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Phase IIIProduct Type: Large molecule
Partner/Sponsor/Collaborator: Qualigen
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Merger April 28, 2020
Details:
The merged company will focus on the development of Qualigen’s nanotechnology therapies for the treatment of cancer and infectious diseases, while also continuing to operate its profitable diagnostic business.
Lead Product(s): Galacto-oligosaccharide
Therapeutic Area: Gastroenterology Product Name: Undisclosed
Highest Development Status: Phase II/ Phase IIIProduct Type: Large molecule
Partner/Sponsor/Collaborator: Qualigen
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Merger January 21, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
